These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8694519)

  • 1. Introduction to in vivo MRS of cancer: new perspectives and open problems.
    Leach MO
    Anticancer Res; 1996; 16(3B):1503-14. PubMed ID: 8694519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholipid metabolites in 1H-decoupled 31P MRS in vivo in human cancer: implications for experimental models and clinical studies.
    Negendank W; Li CW; Padavic-Shaller K; Murphy-Boesch J; Brown TR
    Anticancer Res; 1996; 16(3B):1539-44. PubMed ID: 8694523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance spectroscopy applied to clinical oncology.
    Leach MO
    Technol Health Care; 1994 Dec; 2(4):235-46. PubMed ID: 7842308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR spectroscopy of musculoskeletal soft-tissue tumors.
    Negendank WG
    Magn Reson Imaging Clin N Am; 1995 Nov; 3(4):713-25. PubMed ID: 8564691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance spectroscopic studies of the prostate.
    Koutcher JA; Zakian K; Hricak H
    Mol Urol; 2000; 4(3):143-52;discussion 153. PubMed ID: 11062368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
    Fayed N; Dávila J; Medrano J; Olmos S
    Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the assessment of serum markers in patients with lung cancer aid in the clinical decision making process?
    Ebert W; Muley T; Drings P
    Anticancer Res; 1996; 16(4B):2161-8. PubMed ID: 8694537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo magnetic resonance spectroscopy of gynaecological tumours at 3.0 Tesla.
    Booth SJ; Pickles MD; Turnbull LW
    BJOG; 2009 Jan; 116(2):300-3. PubMed ID: 19076962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma.
    Mun CW; Cho JY; Shin WJ; Choi KS; Eun CK; Cha SS; Lee J; Yang YI; Nam SH; Kim J; Lee SY
    Magn Reson Imaging; 2004 Jul; 22(6):861-70. PubMed ID: 15234456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vivo magnetic resonance spectroscopy].
    Bakken IJ; Skjetne T; Gribbestad IS; Kvistad KA
    Tidsskr Nor Laegeforen; 2002 May; 122(14):1365-8. PubMed ID: 12098905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy.
    Muruganandham M; Alfieri AA; Matei C; Chen Y; Sukenick G; Schemainda I; Hasmann M; Saltz LB; Koutcher JA
    Clin Cancer Res; 2005 May; 11(9):3503-13. PubMed ID: 15867253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heteronuclear multivoxel spectroscopy of in vivo human brain: two-dimensional proton interleaved with three-dimensional 1H-decoupled phosphorus chemical shift imaging.
    Arias-Mendoza F; Javaid T; Stoyanova R; Brown TR; Gonen O
    NMR Biomed; 1996 May; 9(3):105-13. PubMed ID: 8892396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New techniques in the pharmacokinetic analysis of cancer drugs. III. Nuclear magnetic resonance.
    Maxwell RJ
    Cancer Surv; 1993; 17():415-23. PubMed ID: 8137351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton magnetic resonance spectroscopy in neuroblastoma: current status, prospects and limitations.
    Lindskog M; Spenger C; Klason T; Jarvet J; Gräslund A; Johnsen JI; Ponthan F; Douglas L; Nordell B; Kogner P
    Cancer Lett; 2005 Oct; 228(1-2):247-55. PubMed ID: 15946794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between 31P metabolites and oncolytic viral therapy sensitivity in human colorectal cancer xenografts.
    Silberhumer GR; Zakian K; Malhotra S; Brader P; Gönen M; Koutcher J; Fong Y
    Br J Surg; 2009 Jul; 96(7):809-16. PubMed ID: 19526622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance spectroscopy and imaging methods for measuring tumour and tissue oxygenation.
    McCoy CL; McIntyre DJ; Robinson SP; Aboagye EO; Griffiths JR
    Br J Cancer Suppl; 1996 Jul; 27():S226-31. PubMed ID: 8763886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molar quantitation of hepatic metabolites in vivo in proton-decoupled, nuclear Overhauser effect enhanced 31P NMR spectra localized by three-dimensional chemical shift imaging.
    Li CW; Negendank WG; Murphy-Boesch J; Padavic-Shaller K; Brown TR
    NMR Biomed; 1996 Jun; 9(4):141-55. PubMed ID: 9015801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance spectroscopy in cancer: phospholipid, neutral lipid and lipoprotein metabolism and function.
    Podo F; de Certaines JD
    Anticancer Res; 1996; 16(3B):1305-15. PubMed ID: 8694495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1H MR spectroscopy of brain tumours and masses.
    Howe FA; Opstad KS
    NMR Biomed; 2003 May; 16(3):123-31. PubMed ID: 12884355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of phospholipid metabolites in breast cancer cells treated with antimitotic drugs: a 31P-magnetic resonance spectroscopy study.
    Sterin M; Cohen JS; Mardor Y; Berman E; Ringel I
    Cancer Res; 2001 Oct; 61(20):7536-43. PubMed ID: 11606391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.